Equities

Panacea Biotec Ltd

PANACEABIO:NSI

Panacea Biotec Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)314.09
  • Today's Change-16.54 / -5.00%
  • Shares traded28.69k
  • 1 Year change+93.88%
  • Beta0.9732
Data delayed at least 15 minutes, as of Sep 20 2024 10:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue5,5924,5996,612
OPERATING EXPENSES
Cost of revenue total3,0473,1073,378
Selling, general and admin. expenses, total2,5762,1253,267
Depreciation/amortization367391437
Unusual expense(income)(314)(991)(16754)
Other operating expenses, total522564
Total operating expense5,7284,657(9608)
Operating income(137)(58)16,220
Other, net241528
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes1512814,488
Provision for income taxes304663,709
Net income after taxes(15)(337)10,779
Minority interest3.325.08(0.19)
Net income before extra. Items(12)(332)10,779
Total extraordinary items----0
Net income(12)(332)10,779
Inc.avail. to common excl. extra. Items(12)(332)10,779
Inc.avail. to common incl. extra. Items(12)(332)10,779
EPS RECONCILIATION
Basic/primary weighted average shares616161
Basic/primary eps excl. extra items(0.19)(5.43)176
Basic/primary eps incl. extra items(0.19)(5.43)176
Dilution adjustment------
Diluted weighted average shares616161
Diluted eps excl. extra items(0.19)(5.43)176
Diluted eps incl. extra items(0.19)(5.43)176
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental27381,798
SUPPLEMENTAL INCOME
Depreciation, supplemental343388428
Total special items(315)(1044)(16754)
NORMALISED INCOME
Normalized income before taxes(300)(916)(2266)
Effect of special items on income taxes(110)(365)(5864)
Income tax excluding impact of special items(80)100(2155)
Normalized income after tax(220)(1016)(111)
Normalized income avail. to common(216)(1011)(111)
Basic normalized EPS(3.53)(17)(1.82)
Diluted normalized EPS(3.53)(17)(1.82)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.